3.24
price down icon2.70%   -0.09
after-market Dopo l'orario di chiusura: 3.24
loading
Precedente Chiudi:
$3.33
Aprire:
$3.33
Volume 24 ore:
548.59K
Relative Volume:
0.67
Capitalizzazione di mercato:
$268.42M
Reddito:
$70.14M
Utile/perdita netta:
$-76.24M
Rapporto P/E:
-2.9189
EPS:
-1.11
Flusso di cassa netto:
$-57.06M
1 W Prestazione:
+12.50%
1M Prestazione:
+29.60%
6M Prestazione:
-34.01%
1 anno Prestazione:
-8.99%
Intervallo 1D:
Value
$3.23
$3.335
Intervallo di 1 settimana:
Value
$2.81
$3.38
Portata 52W:
Value
$1.90
$6.08

Codexis Inc Stock (CDXS) Company Profile

Name
Nome
Codexis Inc
Name
Telefono
650-421-8100
Name
Indirizzo
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Name
Dipendente
188
Name
Cinguettio
@codexisinc
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
CDXS's Discussions on Twitter

Confronta CDXS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CDXS
Codexis Inc
3.24 252.68M 70.14M -76.24M -57.06M -1.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Codexis Inc Stock (CDXS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-19 Downgrade The Benchmark Company Buy → Hold
2024-06-03 Ripresa Jefferies Buy
2024-05-30 Iniziato Cantor Fitzgerald Overweight
2024-02-29 Aggiornamento The Benchmark Company Hold → Buy
2023-11-07 Downgrade The Benchmark Company Buy → Hold
2023-08-07 Downgrade TD Cowen Outperform → Market Perform
2023-05-09 Downgrade H.C. Wainwright Buy → Neutral
2022-03-31 Ripresa Piper Sandler Overweight
2022-03-02 Ripresa Cowen Outperform
2021-04-12 Iniziato Piper Sandler Overweight
2021-03-01 Iniziato Stifel Buy
2021-02-26 Reiterato H.C. Wainwright Buy
2020-03-10 Iniziato The Benchmark Company Buy
2019-01-17 Aggiornamento First Analysis Sec Neutral → Outperform
2018-05-16 Iniziato Stephens Overweight
2017-10-13 Reiterato H.C. Wainwright Buy
2017-05-31 Iniziato Jefferies Buy
2017-01-26 Downgrade First Analysis Sec Overweight → Equal-Weight
2017-01-04 Aggiornamento Ladenburg Thalmann Neutral → Buy
2016-01-06 Iniziato H.C. Wainwright Buy
Mostra tutto

Codexis Inc Borsa (CDXS) Ultime notizie

pulisher
Jul 24, 2025

What analysts say about Codexis Inc. stockRapid growth opportunities - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Is Codexis Inc. a good long term investmentFree Popular Stock Recommendations - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

How Codexis Inc. stock compares to its top competitorsIs CNFRZ stock undervalued or overvalued nowSignificant capital appreciation - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Codexis Inc. Stock Analysis and ForecastRobust investment performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Major Shareholder Makes Bold Move with Codexis Stock Purchase - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Enzymatic Solutions Leader Codexis Reveals Growth Strategy at Jefferies Healthcare Conference - Stock Titan

Jul 22, 2025
pulisher
Jul 20, 2025

What drives Codexis Inc. stock priceExceptional gains - Autocar Professional

Jul 20, 2025
pulisher
Jul 15, 2025

What makes Codexis Inc. stock price move sharplyFree Consultation - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Codexis Inc. stock performs during market volatilityFree Market Analysis Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Codexis Inc. stock attracts strong analyst attentionTop Performing Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Biocatalysis And Biocatalyst Market Set for Strong Growth Outlook: Codexis, Amano Enzyme, Biocatalysts - newstrail.com

Jul 15, 2025
pulisher
Jul 11, 2025

Codexis, Inc.'s (NASDAQ:CDXS) P/S Is Still On The Mark Following 27% Share Price Bounce - 富途牛牛

Jul 11, 2025
pulisher
Jul 03, 2025

What You Can Learn From Codexis, Inc.'s (NASDAQ:CDXS) P/S - simplywall.st

Jul 03, 2025
pulisher
Jun 27, 2025

With 59% ownership, Codexis, Inc. (NASDAQ:CDXS) boasts of strong institutional backing - Yahoo.co

Jun 27, 2025
pulisher
Jun 24, 2025

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Perspective Therapeutics (CATX) and Codexis (CDXS) - The Globe and Mail

Jun 24, 2025
pulisher
Jun 18, 2025

Synthetic Biology Market Key Players AnalysisBota - openPR.com

Jun 18, 2025
pulisher
Jun 18, 2025

Codexis, Inc. (NASDAQ:CDXS) Position Increased by Assenagon Asset Management S.A. - Defense World

Jun 18, 2025
pulisher
Jun 16, 2025

Opaleye Management Makes a Bold Move with Codexis Stock Purchase! - TipRanks

Jun 16, 2025
pulisher
Jun 13, 2025

Millennium Management LLC Has $171,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Bank of America Corp DE Has $364,000 Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 13, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Forecasts Codexis FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 08, 2025

Squarepoint Ops LLC Has $253,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Investor Network: Codexis, Inc. to Host Earnings Call - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 05, 2025

Two Sigma Investments LP Buys 6,397 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 05, 2025

Codexis Inc Azioni (CDXS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):